Cita APA

Stahl, A., Nakanishi, H., Lepore, D., Wu, W., Azuma, N., & Jacas, C. (2024). Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next.

Citación estilo Chicago

Stahl, Andreas, Hidehiko Nakanishi, Domenico Lepore, Wei-Chi Wu, Noriyuki Azuma, y Carlos Jacas. Intravitreal Aflibercept Vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE Next. 2024.

Cita MLA

Stahl, Andreas, et al. Intravitreal Aflibercept Vs Laser Therapy for Retinopathy of Prematurity: Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE Next. 2024.